AMSC Reports First Quarter Fiscal 2016 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
AMSC Reports First Quarter Fiscal 2016 Financial Results and Provides Business Outlook

DEVENS, Mass., Aug. 09, 2016 (GLOBE NEWSWIRE) -- AMSC (NASDAQ: AMSC ), a global solutions provider serving wind and power grid industry leaders, today reported financial results for its first quarter of fiscal 2016 ended June 30, 2016. 

Revenues for the first quarter of fiscal 2016 were $13.3 million, compared with $23.7 million for the same period of fiscal 2015. The year over year decrease in revenues was largely due to lower Wind segment revenues during the first quarter of fiscal 2016.

AMSC’s net loss for the first quarter of fiscal 2016 increased to $10.4 million, or $0.76 per share, from $9.1 million, or $0.75 per share, for the same period of fiscal 2015. The Company’s non-GAAP net loss for the first quarter of fiscal 2016 was $8.7 million, or $0.64 per share, which stayed flat compared with a non-GAAP net loss of $8.7 million, or $0.72 per share, in the same period of fiscal 2015. Please refer to the financial table below for a reconciliation of GAAP to non-GAAP results.

Cash, cash equivalents, and restricted cash at June 30, 2016 totaled $36.6 million, compared with $40.7 million at March 31, 2016.

“Considering the working capital constraints of our largest customer, Inox Wind, in the first quarter, our financial performance was in line with our expectations,” said Daniel P. McGahn, President and CEO, AMSC. “We remain focused on executing on our objectives for fiscal 2016 and we believe that our wind segment will generate stronger revenues in the quarters ahead.”

Business Outlook “While Inox has completed making the necessary pre-payments under the contracts executed last December, shipments of our electrical control systems to Inox are expected to be back end loaded in the second quarter,” said McGahn.   For the second quarter ending September 30, 2016, AMSC expects that its revenues will be in the range of $16.0 million to $18.0 million. The Company’s net loss for the second quarter of fiscal 2016 is expected to be less than $12.5 million, or $0.88 per share.  In addition, AMSC expects that its non-GAAP net loss (as defined below) for the second quarter of fiscal 2016 will be less than $12.0 million, or $0.85 per share.

Conference Call Reminder In conjunction with this announcement, AMSC management will participate in a conference call with investors beginning at 10:00 a.m. Eastern Time today to discuss the Company’s financial results and business outlook. Those who wish to listen to the live or archived conference call webcast should visit the “Investors” section of the Company’s website at http://www.amsc.com/investors . The live call also can be accessed by dialing 785-830-1916 and using conference ID 4754410.

About AMSC (NASDAQ: AMSC ) AMSC generates the ideas, technologies and solutions that meet the world’s demand for smarter, cleaner ... better energy™. Through its Windtec™ Solutions, AMSC provides wind turbine electronic controls and systems, designs and engineering services that reduce the cost of wind energy. Through its Gridtec™ Solutions, AMSC provides the engineering planning services and advanced grid systems that optimize network reliability, efficiency and performance. The Company’s solutions are now powering gigawatts of renewable energy globally and are enhancing the performance and reliability of power networks in more than a dozen countries. Founded in 1987, AMSC is headquartered near Boston, Massachusetts with operations in Asia, Australia, Europe and North America. For more information, please visit www.amsc.com .

AMSC, Windtec, Gridtec, and Smarter, Cleaner ... Better Energy are trademarks or registered trademarks of American Superconductor Corporation. All other brand names, product names, trademarks or service marks belong to their respective holders.

Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Any statements in this release about our expectations regarding anticipated financial results, the strength of future revenues in our Wind segment, the timing of shipments of electric control systems to Inox, and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements represent management’s current expectations and are inherently uncertain. There are a number of important factors that could materially impact the value of our common stock or cause actual results to differ materially from those indicated by such forward-looking statements. These important factors include, but are not limited to: A significant portion of our revenues are derived from a single customer, Inox, and shipments to Inox may not commence in the time frame we expect or at all; We have a history of operating losses and negative operating cash flows, which may continue in the future and require us additional financing in the future; Our operating results may fluctuate significantly from quarter to quarter and may fall below expectations in any particular fiscal quarter; Our financial condition may have an adverse effect on our customer and supplier relationships; Our success in addressing the wind energy market is dependent on the manufacturers that license our designs; Our success is dependent upon attracting and retaining qualified personnel and our inability to do so could significantly damage our business and prospects; We rely upon third-party suppliers for the components and sub-assemblies of many of our Wind and Grid products, making us vulnerable to supply shortages and price fluctuations; We may not realize all of the sales expected from our backlog of orders and contracts; Our success depends upon the commercial use of high temperature superconductor (“HTS”) products, which is currently limited, and a widespread commercial market for our products may not develop; Growth of the wind energy market depends largely on the availability and size of government subsidies and economic incentives; We have operations in and depend on sales in emerging markets, including India and China, and global conditions could negatively affect our operating results or limit our ability to expand our operations outside of these countries; We face risks related to our intellectual property; We face risks related to our legal proceedings; and the important factors discussed under the caption “Risk Factors” in Part 1. Item 1A of our Form 10-K for the fiscal year ended March 31, 2016, and our other reports filed with the SEC. These important factors, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

 
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
 
  Three months ended June 30,
  2016   2015
Revenues      
Wind $ 5,675     $ 18,164  
Grid 7,670     5,559  
Total revenues $ 13,345     $ 23,723  
       
Cost of revenues 12,482     20,503  
       
Gross profit 863     3,220  
       
Operating expenses:      
Research and development 2,952     3,162  
Selling, general and administrative 7,216     7,535  
Impairment of minority interest investment —     741  
Amortization of acquisition related intangibles 39     39  
Total operating expenses 10,207     11,477  
       
Operating loss (9,344 )   (8,257 )
       
Change in fair value of derivatives and warrants (678 )   800  
Interest expense, net (135 )   (318 )
Other income (expense), net 126     (772 )
Loss before income tax expense (10,031 )   (8,547 )
       
Income tax expense 324     574  
       
Net loss $ (10,355 )   $ (9,121 )
       
Net loss per common share      
Basic $ (0.76 )   $ (0.75 )
Diluted $ (0.76 )   $ (0.75 )
       
Weighted average number of common shares outstanding      
Basic 13,676     12,111  
Diluted 13,676     12,111  
 
UNAUDITED CONSOLIDATED BALANCE SHEET
(In thousands, except per share data)
 
  June 30,  2016   March 31,  2016
ASSETS      
Current assets:      
Cash and cash equivalents $ 35,211     $ 39,330  
Accounts receivable, net 7,039     19,264  
Inventory 28,887     18,512  
Prepaid expenses and other current assets 4,086     5,778  
Restricted cash 441     457  
Total current assets 75,664     83,341  
       
Property, plant and equipment, net 48,318     49,778  
Intangibles, net 712     854  
Restricted cash 934     934  
Deferred tax assets 94     96  
Other assets 329     315  
Total assets $ 126,051     $ 135,318  
       
LIABILITIES AND STOCKHOLDERS' EQUITY      
       
Current liabilities:      
Accounts payable and accrued expenses $ 24,694     $ 23,156  
Note payable, current portion, net of discount of $119 as of June 30, 2016 and $42 as of March 31, 2016 3,047     2,624  
Derivative liabilities 3,905     3,227  
Deferred revenue 12,752     12,000  
Total current liabilities 44,398     41,007  
       
Note payable, net of discount of $133 as of March 31, 2016 —     1,367  
Deferred revenue 8,344     9,269  
Deferred tax liabilities 63     63  
Other liabilities 57     63  
Total liabilities 52,862     51,769  
       
Commitments and contingencies (Note 12)      
       
Stockholders' equity:      
Common Stock 143     141  
Additional paid-in capital 1,012,918     1,011,813  
Treasury stock (1,341 )   (881 )
Accumulated other comprehensive income 8     660  
Accumulated deficit (938,539 )   (928,184 )
Total stockholders' equity 73,189     83,549  
Total liabilities and stockholders' equity $ 126,051     $ 135,318  
 
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
 
  Three months ended June 30,
  2016   2015
Cash flows from operating activities:      
       
Net loss $ (10,355 )   $ (9,121 )
Adjustments to reconcile net loss to net cash used in operations:      
Depreciation and amortization 1,871     2,028  
Stock-based compensation expense 999     1,128  
Impairment of minority interest investment —     746  
Provision for excess and obsolete inventory 272     602  
Write-off prepaid taxes —     820  
Loss from minority interest investment —     356  
Change in fair value of derivatives and warrants 678     (800 )
Non-cash interest expense 56     111  
Other non-cash items (307 )   553  
Changes in operating asset and liability accounts:      
Accounts receivable 12,192     1,414  
Inventory (10,750 )   2,968  
Prepaid expenses and other current assets 1,555     271  
Accounts payable and accrued expenses 1,650     (3,024 )
Deferred revenue 79     (1,087 )
Net cash used in operating activities (2,060 )   (3,035 )
       
Cash flows from investing activities:      
Net cash used in investing activities (271 )   (64 )
       
Cash flows from financing activities:      
Net cash (used in) / provided by financing activities (1,461 )   21,183  
       
Effect of exchange rate changes on cash and cash equivalents (327 )   (13 )
       
Net (decrease) / increase in cash and cash equivalents (4,119 )   18,071  
Cash and cash equivalents at beginning of period 39,330     20,490  
Cash and cash equivalents at end of period $ 35,211     $ 38,561  

 

 
RECONCILIATION OF GAAP NET INCOME (LOSS) TO NON-GAAP NET INCOME (LOSS)
(In thousands, except per share data)
 
  Three months ended June 30,
  2016   2015
Net loss $ (10,355 )   $ (9,121 )
Stock-based compensation 999     1,128  
Amortization of acquisition-related intangibles 39     39  
Impairment of minority interest investment —     741  
Consumption of zero cost-basis inventory (158 )   (846 )
Change in fair value of derivatives and warrants 678     (800 )
Non-cash interest expense 56     111  
Tax effect of adjustments 25     $ —  
Non-GAAP net loss $ (8,716 )   $ (8,748 )
       
Non-GAAP loss per share $ (0.64 )   $ (0.72 )
Weighted average shares outstanding - basic and diluted 13,676     12,111  
     
Reconciliation of Forecast GAAP Net Loss to Non-GAAP Net Loss  
(In millions, except per share data)  
     
  Three months ending  
September 30, 2016  
Net loss $ (12.5 )  
Stock-based compensation      0.7      
Consumption of zero-cost inventory     (0.2 )    
Non-GAAP net loss $ (12.0 )  
Non-GAAP net loss per share $ (0.85 )  
Shares outstanding   14.1    

Note: Non-GAAP net loss is defined by the Company as net loss before stock-based compensation; amortization of acquisition-related intangibles; impairment of minority interest investment; consumption of zero cost-basis inventory; non-cash interest expense; change in fair value of derivatives and warrants; and other unusual charges, net of any tax effects related to these items. The Company believes non-GAAP net loss assists management and investors in comparing the Company’s performance across reporting periods on a consistent basis by excluding these non-cash, non-recurring or other charges that it does not believe are indicative of its core operating performance. The Company also regards non-GAAP net loss as a useful measure of operating performance to complement operating loss, net loss and other GAAP financial performance measures. In addition, the Company uses non-GAAP net loss as a factor in evaluating management’s performance when determining incentive compensation and to evaluate the effectiveness of its business strategies.

Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures included in this release, however, should be considered in addition to, and not as a substitute for or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of non-GAAP to GAAP net loss is set forth in the table above.

AMSC Contact: Brion D. Tanous AMSC Investor Relations Phone: 424-634-8592 Email: Brion.Tanous@amsc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 42

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 309

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 84

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 92

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Farmmi Receives Extension to Comply with NASDAQ Requirements

Updated Category News Views 64

Farmmi Secures NASDAQ Compliance Extension Farmmi, Inc. (NASDAQ: FAMI), a supplier of agricultural products, has been granted a 180-day extension by NASDAQ to meet its crucial minimum bid price requirement. This extension allows the company until the spring of 2025 to elevate its ordinary share bid price to at least $1.00 for at least ten consecutive business days. The...

Continue Reading
The Neurotechnology Surge: $57B Market by 2034

Updated Category News Views 16

Neurotechnology: The Rising Giant Elbows on the table, let's chew the fat about neurotechnology. The market, dizzyingly projected to soar past USD 57 billion by 2034, is on an explosive trajectory. Folk wiser than us predict an annual growth rate hanging around 14%. This ain't just whispers in coffee shops; it's cold, hard data from DelveInsight’s Market Insights...

Continue Reading
Reviva Pharmaceuticals' New Phase 3 Study for Schizophrenia Drug

Updated Category News Views 99

Reviva Pharmaceuticals' Regulatory Update Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) has recently provided an update regarding their journey with brilaroxazine, a novel drug aimed at treating schizophrenia. This news comes after a pre-New Drug Application meeting with the U.S. Food and Drug Administration (FDA). About Brilaroxazine Brilaroxazine is an innovative...

Continue Reading
Lowe's Reports Strong Earnings Amid Strategic Acquisitions

Updated Category News Views 117

Strong Q2 Earnings Surprise Lowe’s Companies Inc (NYSE: LOW) experienced better-than-expected second quarter earnings, bringing a burst of optimism for investors. The home improvement giant saw its stock increase by approximately 2% shortly after announcing its Q2 financial results. Having recorded solid performance through the quarter, Lowe’s exceeded analysts'...

Continue Reading
Invideo and Kling AI Unite for Game-Changing Visuals

Updated Category News Views 153

Invideo and Kling AI Collaborate to Redefine Video Editing Invideo has recently partnered with Kling AI to introduce an exciting tool known as VFX House. This innovative feature empowers creators with studio-level control for their video projects, offering enhanced capabilities for both marketing and editorial work. Unlocking New Possibilities with VFX House The...

Continue Reading